These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 15823096)

  • 1. Expression of functional recombinant von Willebrand factor-A domain from human complement C2: a potential binding site for C4 and CRIT.
    Hui KM; Orriss GL; Schirmer T; Magnadóttir B; Schifferli JA; Inal JM
    Biochem J; 2005 Aug; 389(Pt 3):863-8. PubMed ID: 15823096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement C2 receptor inhibitor trispanning and the beta-chain of C4 share a binding site for complement C2.
    Inal JM; Schifferli JA
    J Immunol; 2002 May; 168(10):5213-21. PubMed ID: 11994478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRIT peptide interacts with factor B and interferes with alternative pathway activation.
    Hui KM; Magnadóttir B; Schifferli JA; Inal JM
    Biochem Biophys Res Commun; 2006 May; 344(1):308-14. PubMed ID: 16600177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies identify residues 199-216 of the integrin alpha2 vWFA domain as a functionally important region within alpha2beta1.
    Tuckwell DS; Smith L; Korda M; Askari JA; Santoso S; Barnes MJ; Farndale RW; Humphries MJ
    Biochem J; 2000 Sep; 350 Pt 2(Pt 2):485-93. PubMed ID: 10947963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The binding site of human C4b-binding protein on complement C4 is localized in the alpha'-chain.
    Hessing M; van 'T Veer C; Bouma BN
    J Immunol; 1990 Apr; 144(7):2632-7. PubMed ID: 2319131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of early lectin pathway activation in the complement-mediated killing of Trypanosoma cruzi.
    Cestari Idos S; Krarup A; Sim RB; Inal JM; Ramirez MI
    Mol Immunol; 2009 Dec; 47(2-3):426-37. PubMed ID: 19783051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The fourth component of human complement treated with amines or chaotropes or frozen-thawed (C4b-like C4): interaction with C4 binding protein and cleavage by C3b/C4b inactivator.
    von Zabern I; Bloom EL; Chu V; Gigli I
    J Immunol; 1982 Mar; 128(3):1433-8. PubMed ID: 6976993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the C4 and C2 components of complement by a proteinase in serum bactericidal factor, Ra reactive factor.
    Ji YH; Fujita T; Hatsuse H; Takahashi A; Matsushita M; Kawakami M
    J Immunol; 1993 Jan; 150(2):571-8. PubMed ID: 8419490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The secondary structure of the von Willebrand factor type A domain in factor B of human complement by Fourier transform infrared spectroscopy. Its occurrence in collagen types VI, VII, XII and XIV, the integrins and other proteins by averaged structure predictions.
    Perkins SJ; Smith KF; Williams SC; Haris PI; Chapman D; Sim RB
    J Mol Biol; 1994 Apr; 238(1):104-19. PubMed ID: 8145250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of HIV-1 protease cleavage site in human C1-inhibitor.
    Gerencer M; Burek V
    Virus Res; 2004 Sep; 105(1):97-100. PubMed ID: 15325085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for a C4b binding site on the C2b domain of C2.
    Oglesby TJ; Accavitti MA; Volanakis JE
    J Immunol; 1988 Aug; 141(3):926-31. PubMed ID: 3397535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The complement inhibitor, CRIT, undergoes clathrin-dependent endocytosis.
    Inal J; Miot S; Schifferli JA
    Exp Cell Res; 2005 Oct; 310(1):54-65. PubMed ID: 16112669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of complement activation by recombinant Sh-CRIT-ed1 analogues.
    Oh KS; Kweon MH; Rhee KH; Ho Lee K; Sung HC
    Immunology; 2003 Sep; 110(1):73-9. PubMed ID: 12941143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probing the C4-binding site on C1s with monoclonal antibodies. Evidence for a C4/C4b-binding site on the gamma-domain.
    Matsumoto M; Nagaki K; Kitamura H; Kuramitsu S; Nagasawa S; Seya T
    J Immunol; 1989 Apr; 142(8):2743-50. PubMed ID: 2522968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Requirement for the alternative pathway as well as C4 and C2 in complement-dependent hemolysis via the lectin pathway.
    Suankratay C; Zhang XH; Zhang Y; Lint TF; Gewurz H
    J Immunol; 1998 Mar; 160(6):3006-13. PubMed ID: 9510205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between serum amyloid P component and C4b-binding protein associated with inhibition of factor I-mediated C4b degradation.
    García de Frutos P; Dahlbäck B
    J Immunol; 1994 Mar; 152(5):2430-7. PubMed ID: 8133054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular basis of C-reactive protein binding and modulation of complement activation by factor H-related protein 4.
    Hebecker M; Okemefuna AI; Perkins SJ; Mihlan M; Huber-Lang M; Józsi M
    Mol Immunol; 2010 Mar; 47(6):1347-55. PubMed ID: 20042240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phylogeny of regulatory proteins of the complement system. Isolation and characterization of a C4b/C3b inhibitor and a cofactor from sand bass plasma.
    Kaidoh T; Gigli I
    J Immunol; 1989 Mar; 142(5):1605-13. PubMed ID: 2918226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloning and molecular characterization of two complement Bf/C2 genes in large yellow croaker (Pseudosciaena crocea).
    Wei W; Wu H; Xu H; Xu T; Zhang X; Chang K; Zhang Y
    Fish Shellfish Immunol; 2009 Aug; 27(2):285-95. PubMed ID: 19490942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The localization of heparin-binding fragments on human C4b-binding protein.
    Hessing M; Vlooswijk RA; Hackeng TM; Kanters D; Bouma BN
    J Immunol; 1990 Jan; 144(1):204-8. PubMed ID: 2136880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.